Tian L - Search Results

1

Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2.

Liu JY, Wei YQ, Yang L, Zhao X, Tian L, Hou JM, Niu T, Liu F, Jiang Y, Hu B, Wu Y, Su JM, Lou YY, He QM, Wen YJ, Yang JL, Kan B, Mao YQ, Luo F, Peng F. Liu JY, et al. Among authors: tian l. Blood. 2003 Sep 1;102(5):1815-23. doi: 10.1182/blood-2002-12-3772. Epub 2003 May 15. Blood. 2003. PMID: 12750177 Free article.

2

Immunogene therapy of tumors with a vaccine based on the ligand-binding domain of chicken homologous integrin beta3.

Lou YY, Wei YQ, Yang L, Zhao X, Tian L, Lu Y, Wen YJ, Liu F, Huang MJ, Kang B, Xiao F, Su JM, He QM, Xie XJ, Mao YQ, Lei S, Liu JY, Lou F, Zhou LQ, Peng F, Jiang Y, Hu B. Lou YY, et al. Among authors: tian l. Immunol Invest. 2002 Feb;31(1):51-69. doi: 10.1081/imm-120003221. Immunol Invest. 2002. PMID: 11990463

3

Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2.

Su JM, Wei YQ, Tian L, Zhao X, Yang L, He QM, Wang Y, Lu Y, Wu Y, Liu F, Liu JY, Yang JL, Lou YY, Hu B, Niu T, Wen YJ, Xiao F, Deng HX, Li J, Kan B. Su JM, et al. Among authors: tian l. Cancer Res. 2003 Feb 1;63(3):600-7. Cancer Res. 2003. PMID: 12566302

4

Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor receptor.

Lu Y, Wei YQ, Tian L, Zhao X, Yang L, Hu B, Kan B, Wen YJ, Liu F, Deng HX, Li J, Mao YQ, Lei S, Huang MJ, Peng F, Jiang Y, Zhou H, Zhou LQ, Luo F. Lu Y, et al. Among authors: tian l. J Immunol. 2003 Mar 15;170(6):3162-70. doi: 10.4049/jimmunol.170.6.3162. J Immunol. 2003. PMID: 12626574

5

Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice.

He QM, Wei YQ, Tian L, Zhao X, Su JM, Yang L, Lu Y, Kan B, Lou YY, Huang MJ, Xiao F, Liu JY, Hu B, Luo F, Jiang Y, Wen YJ, Deng HX, Li J, Niu T, Yang JL. He QM, et al. Among authors: tian l. J Biol Chem. 2003 Jun 13;278(24):21831-6. doi: 10.1074/jbc.M300880200. Epub 2003 Mar 21. J Biol Chem. 2003. PMID: 12651849 Free article.

6

[Experimental studies on anti-tumor effects of BLC-modified tumor cell vaccine combined with cisplatin].

Zou CH, Tian L, Wei YQ, Zhao X, Kan B, Yang JL, Mao YQ, Wen YJ, Li J, Deng HX. Zou CH, et al. Among authors: tian l. Ai Zheng. 2004 Jan;23(1):1-7. Ai Zheng. 2004. PMID: 14720366 Chinese.

7

[Constructing the tumor cell vaccine based on homologous matrix metalloproteinase-2 and exploring its effects].

Yi T, Tian L, Su JM, Liu J, Wei YQ. Yi T, et al. Among authors: tian l. Sichuan Da Xue Xue Bao Yi Xue Ban. 2004 May;35(3):301-4. Sichuan Da Xue Xue Bao Yi Xue Ban. 2004. PMID: 15181819 Chinese.

8

Active immunotherapy of tumors with a recombinant xenogeneic endoglin as a model antigen.

Tan GH, Wei YQ, Tian L, Zhao X, Yang L, Li J, He QM, Wu Y, Wen YJ, Yi T, Ding ZY, Kan B, Mao YQ, Deng HX, Li HL, Zhou CH, Fu CH, Xiao F, Zhang XW. Tan GH, et al. Among authors: tian l. Eur J Immunol. 2004 Jul;34(7):2012-21. doi: 10.1002/eji.200424933. Eur J Immunol. 2004. PMID: 15214049 Free article.

9

Combination of low-dose cisplatin and recombinant xenogeneic endoglin as a vaccine induces synergistic antitumor activities.

Tan GH, Tian L, Wei YQ, Zhao X, Li J, Wu Y, Wen YJ, Yi T, Ding ZY, Kan B, Mao YQ, Deng HX, Li HL, Zou CH, Fu CH. Tan GH, et al. Among authors: tian l. Int J Cancer. 2004 Nov 20;112(4):701-6. doi: 10.1002/ijc.20449. Int J Cancer. 2004. PMID: 15382054

10

Immunotherapy of tumor by targeting angiogenesis.

Hou J, Tian L, Wei Y. Hou J, et al. Among authors: tian l. Sci China C Life Sci. 2004 Dec;47(6):545-52. doi: 10.1360/04yc0044. Sci China C Life Sci. 2004. PMID: 15620111 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,656 results

Search Page

Filters